NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Triple-Negative Breast Cancer Treatment Market By Drug Type (Cyclophosphamide, Paclitaxel, Carboplatin/Cisplatin, Docetaxel, Doxorubicin, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

纽约，美国，9月25日，2023年（GLOBE NEWSWIRE）-锡安市场研究公司发表了一份新的研究报告，题为“按药物类型（环磷酰胺，紫杉醇，卡铂/顺铂，多西紫杉醇，多柔比星等）划分的三阴性乳腺癌治疗市场”全球和区域产业概况，市场情报，综合分析，历史数据和预测2023-2030年“研究数据库。

“According to the latest research study, the global Triple-Negative Breast Cancer Treatment Market size was valued at around USD 11 billion in 2022. The market is expected to grow at a CAGR of 12.1% and is anticipated to reach a value of USD 20 billion by 2030.” Triple-Negative Breast Cancer Treatment Market Overview: The absence of clinically substantial levels of human epidermal growth factor receptor 2 expressions, progesterone receptor expressions, and estrogen receptor expressions characterizes triple-negative breast cancer.

“根据最新研究，2022年全球三阴性乳腺癌治疗市场规模约为110亿美元。预计该市场将以12.1%的CAGR增长，预计到2030年将达到200亿美元。”三阴性乳腺癌治疗市场概述：缺乏临床上大量的人表皮生长因子受体2表达，孕激素受体表达和雌激素受体表达是三阴性乳腺癌的特征。

This form of breast cancer has fewer treatment options than other types of breast cancer and is the leading cause of death among women. In addition, immune checkpoint inhibitors have had a significant impact on patient treatment outcomes, resulting in a paradigm shift in the treatment of triple-negative malignancies for programmed death ligand 1 (PD-L1).

这种形式的乳腺癌比其他类型的乳腺癌具有更少的治疗选择，并且是女性死亡的主要原因。此外，免疫检查点抑制剂对患者治疗结果具有显着影响，导致程序性死亡配体1（PD-L1）的三阴性恶性肿瘤治疗的范式转变。

Get a Free Sample PDF of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/triple-negative-breast-cancer-treatment-market (A free sample of this report is available upon request; please contact us for more information.) Report Scope: Report AttributeReport DetailsMarket Size in 2022USD 11 BillionMarket Forecast in 2030USD 20 BillionGrowth RateCAGR of 12.1% Base Year2022Forecast Years2023- 2030Regions CoveredNorth America,.

获取本研究报告的免费样本PDF以获取更多见解-https://www.zionmarketresearch.com/sample/triple-negative-breast-cancer-treatment-market（可根据要求提供本报告的免费样本；请与我们联系以获取更多信息。）报告范围：报告属性报告详细信息2022年市场规模120亿美元2030年市场预测200亿美元增长率CAGR为12.1%基准年2022年预测年-2030年覆盖北美地区，。